Thick melanoma: the challenge persists
- PMID: 15656809
- DOI: 10.1111/j.1365-2133.2005.06409.x
Thick melanoma: the challenge persists
Abstract
Background: Considerable resources have been channelled into primary and secondary prevention of cutaneous melanoma over the past 20 years. These efforts have been associated with a significant increase in the proportion of thin, good prognosis lesions and this is felt to be the principal reason for the current overall improvement in melanoma survival.
Objectives: Analysis of Scottish Melanoma Group (SMG) data was carried out to identify the proportion of thick melanomas presenting over time. SMG data were used to characterize the patients presenting with thick melanoma.
Methods: Using data from the SMG database 915 patients (392 male and 523 female) first diagnosed with invasive melanoma > or = 3.5 mm thick in the two decades between 1979 and 1998, inclusive, were identified. The patients were from regions designated South-east Scotland, Tayside, Grampian and Highland, which together form half of all Scottish cases.
Results: The analysis shows that, although the proportion of thick, poor prognosis melanomas has decreased over time, the number presenting per year has not significantly altered. In the first decade, 50.5% of registrations were thick lesions and these fell to 31.0% in the second decade. In the first decade there were 419 cases (173 male), median age 66 years (range 5-99). Fifty-five patients were under the age of 40 years. Two hundred and twelve melanomas were nodular, 116 superficial spreading (SSM), 34 acral and 26 lentigo maligna melanoma. Sixty-nine patients had either lymph node involvement or distant spread at presentation. Despite a 93.3% increase in the total number of melanoma registrations by the end of the second decade, there was relatively little change in the absolute numbers of thick lesions. The total number of thick lesions was 496 (220 male), an increase of 18.4%. Median age was greater, at 70 years (range 1-98), and 31 patients were under the age of 40 years. Nodular was still the commonest type but its proportion had dropped significantly compared with the first decade, with a corresponding increase in SSM and acral types.
Conclusions: Over a 20-year period there was little change in the absolute number of patients presenting with thick melanoma each year, though these form a diminishing proportion of the rising number of total melanomas. This thick melanoma group is characterized by an increasingly older age group and a changing type profile, nodular and SSM being the most common types. This work suggests that the resources currently directed at public and professional education on melanoma are having no effect on this group of patients and that alternative strategies may need to be considered.
Similar articles
-
Thick melanoma: the problem continues.J Eur Acad Dermatol Venereol. 2008 May;22(5):575-9. doi: 10.1111/j.1468-3083.2007.02517.x. Epub 2007 Dec 13. J Eur Acad Dermatol Venereol. 2008. PMID: 18081751
-
Early detection of thick melanomas in the United States: beware of the nodular subtype.Arch Dermatol. 2005 Jun;141(6):745-50. doi: 10.1001/archderm.141.6.745. Arch Dermatol. 2005. PMID: 15967921
-
Malignant melanoma of the head and neck in Scotland: an eight-year analysis of trends in prevalence, distribution and prognosis.Q J Med. 1987 Aug;64(244):661-70. Q J Med. 1987. PMID: 3444872
-
Cutaneous malignant melanoma in the older patient.Dermatol Clin. 1986 Jul;4(3):473-80. Dermatol Clin. 1986. PMID: 3521992 Review.
-
Differences in malignant melanoma between children and adolescents. A 35-year epidemiological study.Arch Dermatol. 1997 Mar;133(3):295-7. Arch Dermatol. 1997. PMID: 9080889 Review.
Cited by
-
Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003.Br J Cancer. 2006 Jul 3;95(1):91-5. doi: 10.1038/sj.bjc.6603216. Epub 2006 Jun 6. Br J Cancer. 2006. PMID: 16755289 Free PMC article.
-
Increased C-MYC copy numbers on the background of CDKN2A loss is associated with improved survival in nodular melanoma.J Cancer Res Clin Oncol. 2007 Feb;133(2):117-23. doi: 10.1007/s00432-006-0150-4. Epub 2006 Sep 15. J Cancer Res Clin Oncol. 2007. PMID: 16977458 Free PMC article.
-
Increasing melanoma awareness among health and social care professionals in secondary care in an era of reduced skin cancer referrals due to COVID-19.Clin Exp Dermatol. 2020 Oct;45(7):920-921. doi: 10.1111/ced.14323. Epub 2020 Jul 22. Clin Exp Dermatol. 2020. PMID: 32485048 Free PMC article. No abstract available.
-
Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study.J Am Acad Dermatol. 2016 Oct;75(4):698-705. doi: 10.1016/j.jaad.2016.05.011. Epub 2016 Jul 16. J Am Acad Dermatol. 2016. PMID: 27436155 Free PMC article.
-
Sentinel Lymph Node Biopsy in Patients With Thick Primary Cutaneous Melanoma.World J Oncol. 2019 Apr;10(2):112-117. doi: 10.14740/wjon1181. Epub 2019 Apr 20. World J Oncol. 2019. PMID: 31068991 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous